sept 2010 report:
Ore Pharmaceutical Holdings Inc. Announces Financial Results for the Quarter Ended September 30, 2010
Ore Pharmaceuticals (USOTC:ORXE)
Historical Stock Chart
3 Months : October 2010 to January 2011
Click Here for more Ore Pharmaceuticals Charts.
Ore Pharmaceutical Holdings Inc. (OTC: ORXE.PK), today announced its financial results for the three month and nine month periods ended September 30, 2010. Net loss for the three months ended September 30, 2010 was $237,000, or $0.04 per share, as compared to a net loss of $594,000 or $0.11 per share for the three months ended September 30, 2009. There was no revenue for the three month periods ended September 30, 2010 or 2009, respectively. Net loss for the nine months ended September 30, 2010 was $2,307,000 or $0.42 per share, as compared to a net loss of $6,287,000 or $1.15 per share for the nine months ended September 30, 2009. There was no revenue for the nine months ended September 30, 2010 and $25,000 in revenue for the nine months ended September 30, 2009.
As previously reported, Ore has suspended its SEC registration and no longer provides financial or other information through SEC filings. Ore intends to continue to provide quarterly and annual financial information by posting such information on its web site, www.orepharma.com.
Ore Pharmaceutical Holdings Overview
Ore Pharmaceutical Holdings Inc. is currently focused on developing and monetizing its current portfolio of pharmaceutical assets, which includes four clinical stage compounds in-licensed from major pharmaceutical companies.
